Y. Beyazit Et Al. , "Role of IL-6 activated STAT3 and TNF expression in obesity-associated hepatocellular carcinoma," ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.32, no.2, pp.304-305, 2010
Beyazit, Y. Et Al. 2010. Role of IL-6 activated STAT3 and TNF expression in obesity-associated hepatocellular carcinoma. ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.32, no.2 , 304-305.
Beyazit, Y., KEKILLI, M., KURT, M., SAYILIR, A., TAS, A., & ONAL, I. K., (2010). Role of IL-6 activated STAT3 and TNF expression in obesity-associated hepatocellular carcinoma. ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.32, no.2, 304-305.
Beyazit, YAVUZ Et Al. "Role of IL-6 activated STAT3 and TNF expression in obesity-associated hepatocellular carcinoma," ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.32, no.2, 304-305, 2010
Beyazit, YAVUZ Et Al. "Role of IL-6 activated STAT3 and TNF expression in obesity-associated hepatocellular carcinoma." ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.32, no.2, pp.304-305, 2010
Beyazit, Y. Et Al. (2010) . "Role of IL-6 activated STAT3 and TNF expression in obesity-associated hepatocellular carcinoma." ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.32, no.2, pp.304-305.
@article{article, author={YAVUZ BEYAZIT Et Al. }, title={Role of IL-6 activated STAT3 and TNF expression in obesity-associated hepatocellular carcinoma}, journal={ALIMENTARY PHARMACOLOGY & THERAPEUTICS}, year=2010, pages={304-305} }